Whole exome sequencing in familial isolated primary hyperparathyroidism.


Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 03 07 2019
accepted: 29 08 2019
pubmed: 6 9 2019
medline: 6 11 2020
entrez: 6 9 2019
Statut: ppublish

Résumé

Familial isolated hyperparathyroidism (FIHP) is a rare inherited disease accounting for 1% of all cases of primary hyperparathyroidism (PHPT). It is genetically heterogeneous being associated with mutations in different genes, including MEN1, CDC73, CASR, and recently GCM2. The aim of the study was to further investigate the molecular pathogenesis in Italian FIHP kindreds. We used whole exome sequencing (WES) in the probands of seven unrelated FIHP kindreds. We carried out a separate family-based exome analysis in a large family characterized by the co-occurrence of PHPT with multiple tumors apparently unrelated to the disease. Selected variants were also screened in 18 additional FIHP kindreds. The clinical, biochemical, and pathological characteristics of the families were also investigated. Three different variants in GCM2 gene were found in two families, but only one (p.Tyr394Ser), already been shown to be pathogenic in vitro, segregated with the disease. Six probands carried seven heterozygous missense mutations segregating with the disease in the FAT3, PARK2, HDAC4, ITPR2 and TBCE genes. A genetic variant in the APC gene co-segregating with PHPT (p.Val530Ala) was detected in a family whose affected relatives had additional tumors, including colonic polyposis. We confirm the role of GCM2 germline mutations in the pathogenesis of FIHP, although at a lower rate than in the previous WES study. Further studies are needed to establish the prevalence and the role in the predisposition to FIHP of the novel variants in additional genes.

Identifiants

pubmed: 31486992
doi: 10.1007/s40618-019-01107-5
pii: 10.1007/s40618-019-01107-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-245

Commentaires et corrections

Type : ErratumIn

Références

Surgery. 2018 Jan;163(1):31-34
pubmed: 29108698
Am J Hum Genet. 2015 Feb 5;96(2):301-8
pubmed: 25640678
Horm Res. 2007;67(1):12-21
pubmed: 17008776
Am J Pathol. 1999 Jan;154(1):127-35
pubmed: 9916927
Cold Spring Harb Mol Case Stud. 2017 Nov 21;3(6):
pubmed: 29162654
Hum Mutat. 2017 Dec;38(12):1621-1648
pubmed: 28881068
Cancer Res. 2008 Sep 1;68(17):6969-77
pubmed: 18757411
J Clin Endocrinol Metab. 2019 Jun 1;104(6):1948-1952
pubmed: 30624640
Am J Surg Pathol. 2002 Jan;26(1):103-10
pubmed: 11756777
PLoS One. 2017 Oct 16;12(10):e0186485
pubmed: 29036195
Endocr Relat Cancer. 2019 Feb 1;26(2):R53-R72
pubmed: 30475215
J Endocr Soc. 2018 Sep 03;3(3):544-559
pubmed: 30788456
J Endocr Soc. 2017 Mar 23;1(5):488-499
pubmed: 29264504
Int J Cancer. 2019 Feb 1;144(3):525-532
pubmed: 30362515
FEBS J. 2015 May;282(9):1736-44
pubmed: 25244360
Mol Cell Biol. 2013 Nov;33(22):4473-91
pubmed: 24043307
Mol Cancer. 2010 Nov 15;9:294
pubmed: 21078161
Mov Disord. 2018 May;33(5):730-741
pubmed: 29644727
Nat Genet. 2014 Jun;46(6):527-8
pubmed: 24866187
Sci Rep. 2015 Sep 18;5:14283
pubmed: 26381817
Am J Hum Genet. 2016 Nov 3;99(5):1034-1044
pubmed: 27745835
J Clin Endocrinol Metab. 2016 Dec;101(12):4611-4617
pubmed: 27623068
J Clin Invest. 2001 Oct;108(8):1215-20
pubmed: 11602629
Front Immunol. 2018 Jan 26;8:1965
pubmed: 29434582
J Clin Endocrinol Metab. 2008 Apr;93(4):1426-32
pubmed: 18182452
Nature. 2000 Jul 13;406(6792):199-203
pubmed: 10910362
J Bone Miner Metab. 2014 Jul;32(4):351-66
pubmed: 24442824
Patholog Res Int. 2015;2015:309348
pubmed: 26697262
Biochim Biophys Acta. 2008 Oct;1783(10):1792-802
pubmed: 18502210
Eur J Hum Genet. 1997 Jan-Feb;5(1):43-9
pubmed: 9156320
Hum Mutat. 2001 May;17(5):434-5
pubmed: 11317365
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15145-50
pubmed: 20696900
Clin Endocrinol (Oxf). 2002 Apr;56(4):457-64
pubmed: 11966738
Tech Coloproctol. 2013 Feb;17(1):79-87
pubmed: 22976915
Nat Commun. 2014 May 06;5:3792
pubmed: 24797322
JCI Insight. 2017 Mar 23;2(6):e92061
pubmed: 28352668
Bioinformatics. 2015 Mar 1;31(5):761-3
pubmed: 25338716
J Natl Cancer Inst. 2015 Dec 17;108(3):
pubmed: 26683220
J Pathol. 2013 Jul;230(3):249-60
pubmed: 23616356
Mamm Genome. 2010 Oct;21(9-10):450-7
pubmed: 20886217
J Clin Endocrinol Metab. 2019 Mar 08;:
pubmed: 30848815
Hered Cancer Clin Pract. 2017 Mar 16;15:5
pubmed: 28331556
PLoS One. 2014 Sep 19;9(9):e107585
pubmed: 25238391
Trans Am Clin Climatol Assoc. 2016;127:235-244
pubmed: 28066056
Database (Oxford). 2016 Jul 03;2016:
pubmed: 27374120
Eur J Hum Genet. 2015 Jun;23(6):
pubmed: 25248397
J Mol Diagn. 2013 Jan;15(1):31-43
pubmed: 23159591
Clin Genet. 2018 Mar;93(3):429-438
pubmed: 28977688
Bioinformatics. 2019 Jun 1;35(11):1978-1980
pubmed: 30376034
Nat Genet. 2014 Jun;46(6):588-94
pubmed: 24793136

Auteurs

F Cetani (F)

University Hospital of Pisa, Endocrine Unit 2, Via Paradisa 2, 56124, Pisa, Italy. cetani@endoc.med.unipi.it.

E Pardi (E)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

P Aretini (P)

Fondazione Pisana per la Scienza ONLUS, Pisa, Italy.

F Saponaro (F)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

S Borsari (S)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

L Mazoni (L)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

M Apicella (M)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

P Civita (P)

Fondazione Pisana per la Scienza ONLUS, Pisa, Italy.

M La Ferla (M)

Fondazione Pisana per la Scienza ONLUS, Pisa, Italy.

M A Caligo (MA)

Molecular Genetics Unit, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy.

F Lessi (F)

Fondazione Pisana per la Scienza ONLUS, Pisa, Italy.

C M Mazzanti (CM)

Fondazione Pisana per la Scienza ONLUS, Pisa, Italy.

L Torregossa (L)

Division of Surgical Pathology, University Hospital of Pisa, Pisa, Italy.

A Oppo (A)

Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

C Marcocci (C)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH